Literature DB >> 19901841

Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial.

Stefan Lüders1, Joachim Schrader, Roland E Schmieder, Wenefrieda Smolka, Karl Wegscheider, Kurt Bestehorn.   

Abstract

INTRODUCTION: We aimed to assess whether hypertension management with a structured physician information program and a feedback system leads to improved blood pressure (BP) control and cardiovascular outcomes.
METHODS: Cluster randomized (3 : 1), open, monitored, multicenter trial in Germany. Primary care-based physicians in the information group (IG) received detailed training on hypertension guidelines, feedback on target-level attainment, and a reminder to intensify treatment after each patient visit, whereas the observation/control group (CG) did not receive any such measures. A three-level mixed model was developed. Time-independent level differences between groups, group-independent changes, and nonparallel group-specific changes over time were tested.
RESULTS: A total of 15 041 (78.1%) hypertensive patients were in the IG and 4213 (21.9%) in the CG. By 1-year follow-up, 82.9% of patients in the IG and 81.5% in the CG remained in the study. The guideline-oriented BP target was attained by 56.8% in the IG and 52.5% in the CG (+4.3%, P = 0.03), whereas the individual BP target was attained by 57.0% in the IG and 51% in the CG (P = NS). BP control in the IG was achieved 2 months earlier on average. Clinical inertia, defined as the absence of medication changes, despite noncontrol of BP, occurred significantly less often in the IG group. One-year cardiovascular outcomes did not differ between groups.
CONCLUSION: The delivery of systematic information in connection with a feedback system reduces clinical inertia and improves guideline adherence. Although compared with earlier studies, the hypertension control rates obtained are higher, there is still considerable room for improvement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19901841     DOI: 10.1097/HJR.0b013e328330be62

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  19 in total

1.  Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial.

Authors:  Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

2.  Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study.

Authors:  Vicente Gil-Guillén; Domingo Orozco-Beltrán; Emilio Márquez-Contreras; Ramón Durazo-Arvizu; Richard Cooper; Salvador Pita-Fernández; Diego González-Segura; Concepción Carratalá-Munuera; José Luis Martín de Pablo; Vicente Pallarés; Salvador Pertusa-Martínez; Antonio Fernández; Josep Redón
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

3.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

4.  Hypertension Management in Primary Care.

Authors:  Birgitta Weltermann; Christine Kersting; Anja Viehmann
Journal:  Dtsch Arztebl Int       Date:  2016-03-11       Impact factor: 5.594

5.  Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary.

Authors:  Endre Szigethy; Zoltán Jancsó; Csaba Móczár; István Ilyés; Eszter Kovács; László Róbert Kolozsvári; Imre Rurik
Journal:  Wien Klin Wochenschr       Date:  2013-07-04       Impact factor: 1.704

6.  Beliefs and practices of Greek doctors in relation to patients' adherence to antihypertensive medication.

Authors:  A Barbouni; M Nalmpanti; D Gennimata; D Theodoridis; K Merakou
Journal:  J Hum Hypertens       Date:  2016-12-29       Impact factor: 3.012

7.  Value of a facilitated quality improvement initiative on cardiovascular disease risk: findings from an evaluation of the Aggressively Treating Global Cardiometabolic Risk Factors to Reduce Cardiovascular Events (AT GOAL).

Authors:  Jan L Losby; Thearis A Osuji; Marnie J House; Rachel Davis; Simone Peart Boyce; Michael Canter Greenberg; John M Whitehill
Journal:  J Eval Clin Pract       Date:  2015-07-30       Impact factor: 2.431

8.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

Review 9.  The effects of on-screen, point of care computer reminders on processes and outcomes of care.

Authors:  Kaveh G Shojania; Alison Jennings; Alain Mayhew; Craig R Ramsay; Martin P Eccles; Jeremy Grimshaw
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Patient and physician adherence in hypertension management.

Authors:  J Rick Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.